ArticleBritish journal of cancer2025

TIGIT antibody with PVR competitive ability enhances cancer immunotherapy and capable of eliciting anti-tumour immune memory.

Huijuan Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.